Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial

PIONEER 5 Investigators

Research output: Contribution to journalArticle

34 Scopus citations

Fingerprint Dive into the research topics of 'Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial'. Together they form a unique fingerprint.

Medicine & Life Sciences